Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology

TOKYO and BOSTON, July 21, 2020 /PRNewswire/ -- and July 22, 2020 - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment of pain associated...

from PR Newswire: https://ift.tt/2DZpOdc